Raia Drogasil Stock Price

RADL3 Community Fair Values

• AN

  

  AnalystConsensusTarget

  Consensus Narrative from 15 Analysts

  Investments In Healthcare And AI Will Drive Future Operational Efficiencies And Profitability

  Key Takeaways Focused investment in organic growth and digital channels aims to expand market share and boost long-term revenue through increased pharmacy footprint and online sales. Strategic healthcare and AI investments could lead to new revenue streams and efficiencies, while customer loyalty initiatives drive repeat sales and profitability.

  R$19.44

  FV

  29.5% undervalued intrinsic discount

  14.05%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  5users have followed this narrative

  2 days ago author updated this narrative
• AN

  

  AnalystLowTarget

  Consensus Narrative from 15 Analysts

  Telemedicine Surge And Brazil Pricing Will Shrink Margins

  Key Takeaways Virtual healthcare adoption and tighter drug pricing rules are constraining revenue growth and compressing margins across Raia Drogasil's retail operations. Competitive pressures and shifting consumer preferences are undermining store productivity, leading to weaker-than-expected earnings growth despite significant investments.

  R$14.50

  FV

  5.5% undervalued intrinsic discount

  12.61%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  0users have followed this narrative

  about 1 month ago author updated this narrative
• AN

  

  AnalystHighTarget

  Consensus Narrative from 15 Analysts

  Aging, Digitalization And Urbanization Will Drive Healthcare Growth

  Key Takeaways Expanding digital and physical networks uniquely position Raia Drogasil to capture long-term market share, drive premium sales, and outperform consensus revenue and margin growth expectations. Aging demographics, proprietary offerings, and operational advances will accelerate recurring sales, boost efficiency, and deliver resilient, above-industry earnings regardless of economic headwinds.

  R$28.74

  FV

  52.3% undervalued intrinsic discount

  19.20%

  Revenue growth p.a.

  0users have liked this narrative

  0users have commented on this narrative

  0users have followed this narrative

  9 days ago author updated this narrative